1. Home
  2. KAI vs LGND Comparison

KAI vs LGND Comparison

Compare KAI & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kadant Inc

KAI

Kadant Inc

HOLD

Current Price

$289.69

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$189.25

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KAI
LGND
Founded
1991
1987
Country
United States
United States
Employees
N/A
68
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.9B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
KAI
LGND
Price
$289.69
$189.25
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$340.00
$144.71
AVG Volume (30 Days)
143.8K
139.7K
Earning Date
10-28-2025
08-05-2025
Dividend Yield
0.47%
N/A
EPS Growth
N/A
N/A
EPS
8.65
N/A
Revenue
$1,024,074,000.00
$181,488,000.00
Revenue This Year
N/A
$18.41
Revenue Next Year
$10.56
$18.87
P/E Ratio
$33.78
N/A
Revenue Growth
N/A
53.40
52 Week Low
$244.87
$81.74
52 Week High
$409.73
$129.90

Technical Indicators

Market Signals
Indicator
KAI
LGND
Relative Strength Index (RSI) 57.58 45.58
Support Level $276.80 $179.65
Resistance Level $300.44 $192.44
Average True Range (ATR) 9.69 6.57
MACD 2.66 -2.06
Stochastic Oscillator 72.75 31.70

Price Performance

Historical Comparison
KAI
LGND

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: